Stock ZYDUSLIFE ZYDUS LIFESCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Zydus Lifesciences Limited

Equities

ZYDUSLIFE

INE010B01027

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 05:10:49 29/04/2024 pm IST 		5-day change 1st Jan Change
963.1 INR +1.66% Intraday chart for Zydus Lifesciences Limited +4.44% +39.74%
26/04 Weak March Quarter Earnings Weigh Down Indian Equities on Friday MT
26/04 Zydus Lifesciences Gets US FDA's Final Approval for Generic Acne Cream MT

Business Summary

Zydus Lifesciences Limited is an India-based global life sciences company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The Company is engaged in the business of integrated pharmaceutical operations. Its product portfolio includes active pharmaceutical ingredients (API), human formulations, animal health and veterinary, health, and wellness products. Its products include India formulations, Generics and Zydus biologics. The Company's products include Lipaglyn and Bilypsa (Saroglitazar), Ujvira (Trastuzumab emtansine biosimilar), Exemptia (Adalimumab biosimilar), Vivitra (Trastuzumab biosimilar) and Bryxta (Bevacizumab biosimilar). Its Zydus biologics covers various therapeutic areas, such as oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology and infectious illnesses, among others. The Company has a global presence and markets its products in the United States, India, Europe and emerging markets.

Number of employees: 23,026

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceuticals
87.0 %
132,864 87.0 % 149,926 87.0 % +12.84%
Consumer Products
13.0 %
19,788 13.0 % 22,448 13.0 % +13.44%

Sales per region

INR in Million2022Weight2023Weight Delta
India
44.3 %
72,532 47.5 % 76,399 44.3 % +5.33%
United States
43.4 %
59,487 39.0 % 74,868 43.4 % +25.86%
Others
12.2 %
20,633 13.5 % 21,107 12.2 % +2.30%

Managers

Managers TitleAgeSince
Sharvil Pankajbhai Patel CEO
 Chief Executive Officer 44 01/97/01
Nitin Dalsukhrai Parekh DFI
 Director of Finance/CFO - -
Pankaj Ramanbhai Patel CHM
 Chairman 71 15/95/15
Dhaval Narendra Soni CMP
 Compliance Officer - 07/19/07
Ganesh Narayan Nayak BRD
 Director/Board Member 68 01/77/01
Arvind Bothra IRC
 Investor Relations Contact - -
Mathew George PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Bhadresh Kantilal Shah BRD
 Director/Board Member 72 06/18/06
Pankaj Ramanbhai Patel CHM
 Chairman 71 15/95/15
Mukesh Mangalbhai Patel BRD
 Director/Board Member 69 01/97/01
Sharvil Pankajbhai Patel CEO
 Chief Executive Officer 44 01/97/01
Apurva Shishir Diwanji BRD
 Director/Board Member 55 16/03/16
Ganesh Narayan Nayak BRD
 Director/Board Member 68 01/77/01
Akhil Monappa BRD
 Director/Board Member 44 29/22/29
Nitin Raojibhai Desai BRD
 Director/Board Member 81 06/11/06
Dharmishtaben N. Raval BRD
 Director/Board Member 68 16/14/16
Upasana Kamineni Konidela BRD
 Director/Board Member 37 29/22/29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,006,233,990 250,227,197 ( 24.87 %) 0 24.87 %

Shareholders

NameEquities%Valuation
Patel Family
75.41 %
758,788,706 75.41 % 9 146 M ₹
Life Insurance Corporation of India (Investment Portfolio)
6.015 %
60,525,602 6.015 % 730 M ₹
Kotak Mahindra Asset Management Co. Ltd.
2.350 %
23,650,108 2.350 % 285 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
0.8731 %
8,785,008 0.8731 % 106 M ₹
PPFAS Asset Management Private Ltd.
0.8004 %
8,054,030 0.8004 % 97 M ₹
Nippon Life India Asset Management Ltd. (Invt Mgmt)
0.6062 %
6,099,681 0.6062 % 74 M ₹
Tata Asset Management Ltd.
0.5787 %
5,822,631 0.5787 % 70 M ₹
Sundaram Asset Management Co. Ltd.
0.3309 %
3,329,528 0.3309 % 40 M ₹
HDFC Life Insurance Co. Ltd. (Investment Portfolio)
0.2650 %
2,666,921 0.2650 % 32 M ₹
HSBC Asset Management (India) Pvt Ltd.
0.2005 %
2,017,500 0.2005 % 24 M ₹

Holdings

NameEquities%Valuation
ZYDUS WELLNESS LIMITED
57.59%
 36,647,509 57.59% 646,321,332 $

Company contact information

Zydus Lifesciences Ltd.

Zydus Corporate Park Scheme No. 63, Survey No. 536

382481, Ahmedabad

+91 79 7180 0000

http://www.zyduscadila.com
address Zydus Lifesciences Limited(ZYDUSLIFE)

Group companies

NameCategory and Sector
ZYDUS WELLNESS LIMITED
Food: Major Diversified
Zydus Pharmaceuticals Ltd.
Logo Zydus Pharmaceuticals Ltd.

Zydus Pharmaceuticals Ltd.

Medical DistributorsDistribution Services

Zydus Pharmaceuticals Ltd. distributes pharmaceuticals and cosmetics products. The company is headquartered in Ahmedabad, India.

Medical Distributors
Alidac Pharmaceuticals Ltd.
Logo Alidac Pharmaceuticals Ltd.

Alidac Pharmaceuticals Ltd.

Pharmaceuticals: MajorHealth Technology

Part of Zydus Lifesciences Ltd., Alidac Pharmaceuticals Ltd. is an Indian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Matoda, India.

Pharmaceuticals: Major
Zydus Wellness Products Ltd.
Logo Zydus Wellness Products Ltd.

Zydus Wellness Products Ltd.

Pharmaceuticals: OtherHealth Technology

Zydus Wellness Products Ltd. is an Indian company that manufactures health and wellness products.

Pharmaceuticals: Other
Zydus Vtec Ltd.

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sales per region

Ratings for Zydus Lifesciences Limited

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
963.1 INR
Average target price
844.6 INR
Spread / Average Target
-12.30%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+39.74% 11.43B
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.81% 43.34B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.44% 21.96B
SANDOZ GROUP AG Stock Sandoz Group AG
+13.30% 14.09B
CIPLA LIMITED Stock Cipla Limited
+12.97% 13.64B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.59% 6.86B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+8.46% 5.22B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. Stock Shenzhen Salubris Pharmaceuticals Co., Ltd.
-2.57% 4.71B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ZYDUSLIFE Stock
  4. Company Zydus Lifesciences Limited